ecoli-uk.com

E.coli O157 & Haemolytic Uraemic Syndrome


Trial of Eculizumab for HUS approved

26th December 2015

The trial for the drug Eculizumab for HUS sufferers has been approved. The study is known as the ECUSTEC. The drug is currently being used by aHUS sufferers. The Charity welcomes the trial which will start in 2016 as it is hoped that it will help improve the outcome for sufferers of HUS. To date there has been no specific treatment.

The Charity is one of the co-applicants for the drug based on the fact that there has been no such treatments previously. Whilst only time will tell whether or not the drug will work, we can only hope that it will be beneficial long term for such sufferers. The trial will take several years to complete.




Page
1 of 49
Next > Last >>

22nd December 2024

UK Health Security Agency  By email  ste... ...read on
5th November 2024

This Freedom of information request is in relation to the publication date for an outbreak report of E.coli O157 in 2022, where there was 259 reported cases from consuming salad products. ... ...read on
8th October 2024

By email  steve@ecoli-uk.com ... ...read on
9th September 2024

As you are aware, this matter relates to a complaint to the ICO with regard to the UKHSA’s failure to respond to my request for information, made under FOIA, dated 1st July 2024. ... ...read on
13th August 2024

The Information Commissioner’s Office (ICO) now has to decide if the UK Health Security Agency (UKHSA) were correct in handling a new Freedom of information request about the 2022 outbreak of E.coli O157 from lettuce and salad leaves... ...read on
Page
1 of 49
Next > Last >>

Designed by Robert Woods. View our Cookie & Privacy Policy